Search
for
Sort by
Research 181–210 of 1000+
- Physiology of the Hypothalamic Pituitary Gonadal Axis in the Male
- Beyond Expectations
- Nutrition and hair
- Management of congenital ichthyoses: European guidelines of care, part two
- Primary cicatricial alopecia
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- STEROIDS AND STEROID-LIKE COMPOUNDS
- Stem cell markers (cytokeratin 15, CD34 and nestin) in primary scarring and nonscarring alopecia
- Botulinum Toxin Off-Label Use in Dermatology: A Review
- Mutant laboratory mice with abnormalities in hair follicle morphogenesis, cycling, and/or structure: An update
- Alopecia Areata
- Recent Progress in Prostaglandin F<sub>2</sub><i><sub>α</sub></i>Ethanolamide (Prostamide F<sub>2</sub><i><sub>α</sub></i>) Research and Therapeutics
- The Role of Adipocytes in Tissue Regeneration and Stem Cell Niches
- Chemoprevention of smoke-induced alopecia in mice by oral administration of l-cystine and vitamin B6
- Subacute cutaneous lupus erythematosus presenting as erythroderma
- A Practical Approach to the Diagnosis and Management of Hair Loss in Children and Adolescents
- Update on the dermatologic use of systemic glucocorticosteroids
- Anabolic-androgenic steroids and cardiovascular risk
- Redefining hormone resistance in prostate cancer
- The Clinical Presentation of Systemic Lupus Erythematosus
- Black women’s hair: the main scalp dermatoses and aesthetic practices in women of African ethnicity
- Cutaneous Lesions in Systemic Lupus Erythematosus
- Effect of<i>Citrullus colocynthis</i>Schrad fruits on testosterone-induced alopecia
- Hair loss in elderly women
- Lymphocytic mediated alopecia: histological classification by pattern analysis
- Gender-Affirming Hormone Therapy for Transgender Men
- Androgen antagonists in androgen target tissues
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Adverse health effects of androgen use